Mahsuk Taylan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahsuk Taylan has a total of 206 co-authors. Here are the top co-authors by number of shared publications:
Melike Demir
Faculty of Medicine, Dicle University, Diyarbakir, Turkey
11 shared publicationsCengizhan Sezgi
Faculty of Medicine, Dicle University, Diyarbakir, Turkey
10 shared publicationsHalide Kaya
Şevket Yılmaz Training and Research Hospital, Bursa, Turkey
10 shared publicationsHadice Selimoglu Sen
Faculty of Medicine, Dicle University, Diyarbakir, Turkey
8 shared publicationsOzlem Abakay
Medical School, Department of Chest Diseases, Dicle University, Diyarbakir, Turkey
8 shared publicationsAbdullah Cetin Tanrikulu
Medical School, Department of Chest Diseases, Dicle University, Diyarbakir, Turkey
6 shared publications
Latest Publications
- 29 June 2026
- Published by Vizetek Publishing Company
Applications of Artificial Intelligence and Machine Learning in Health Sciences
Artificial intelligence and machine learning offer important methods for measurement, data analysis, clinical decision support, drug dose management, and computational examination of biological processes in health sciences. The reliable use of these methods requires correct data, suitable model selection, clear reporting, and careful clinical interpretation. Application of Artificial Intelligence and Machine Learning in Health Science is an academic work that examines artificial intelligence and machine learning applications in health sciences through scientific evidence and measurable data. The book examines anthropometric measurements, respiratory sounds, clinical and genetic variables, drug dose response, molecular motion, energy transfer, and computational modeling. Prepared by expert physicians, academics, and researchers in their fields, this book is an evidence-based, balanced, and scientific source for readers working in medicine, health sciences, biomedical engineering, physiology, pharmacology, clinical decision support systems, and computational biology.
- 29 June 2026
- Published by Vizetek Publishing Company
Applications of Artificial Intelligence and Machine Learning in Health Sciences
Artificial intelligence and machine learning offer important methods for measurement, data analysis, clinical decision support, drug dose management, and computational examination of biological processes in health sciences. The reliable use of these methods requires correct data, suitable model selection, clear reporting, and careful clinical interpretation. Application of Artificial Intelligence and Machine Learning in Health Science is an academic work that examines artificial intelligence and machine learning applications in health sciences through scientific evidence and measurable data. The book examines anthropometric measurements, respiratory sounds, clinical and genetic variables, drug dose response, molecular motion, energy transfer, and computational modeling. Prepared by expert physicians, academics, and researchers in their fields, this book is an evidence-based, balanced, and scientific source for readers working in medicine, health sciences, biomedical engineering, physiology, pharmacology, clinical decision support systems, and computational biology.
- Open Access
- 12 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1909
The Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity
Background/Objectives: The association between past coronavirus disease-19 (COVID-19) infection and pulmonary thromboembolism (PTE) is a potential research topic. We aimed to research the prevalence of previous COVID-19 infection in patients with PTE and to determine whether there is a difference in embolism severity in these cases. Methods: Study design: Multicenter, observational, cross-sectional. Patients diagnosed with PTE between 11 March 2022 and 11 March 2023 were prospectively included in this study, excluding cases with PTE along with active COVID-19, patients under the age of 18, and pregnant patients. Group 1 consisted of PTE cases with previous COVID-19, and Group 2 consisted of PTE cases without previous COVID-19. Key variables are D-Dimer level, right ventricle/left ventricle (RV/LV) ratio, simplified pulmonary embolism severity score, and treatment type. Results: A total of 1185 patients (Group 1; n = 360, Group 2; n = 825) were included in this study. The proportion of patients with RV/LV ratio > 1 on computed tomography pulmonary angiography (CTPA) was significantly high in Group 2 compared to Group 1 (27.9% vs. 19.7%, p = 0.003). In multivariate logistic regression analysis, the absence of any identifiable risk factor for PTE was found to be a 0.46-fold protective factor in the presence of previous COVID-19 (OR: 0.456 95% CI: 0.274–0.760, Wald = 9.070, df = 1, p = 0.003) and an RV/LV ratio > 1 on CTPA was found to be a 0.60-fold protective factor (OR: 0.603, 95% CI: 0.365–0.998, Wald = 3.874, df = 1, p = 0.049). Conclusions: The prevalence of previous COVID-19 infection in PTE cases was 30.4%, and 26.3% of idiopathic cases had previous COVID-19 infection. Although the parameters related to embolism severity were higher in the non-COVID-19 group, multivariate analyses revealed a 2.2-fold increased risk for idiopathic PTE and a 1.7-fold increased risk for RV/LV ratio > 1 on CTPA in patients without COVID-19 compared to those with prior COVID-19.
- 12 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1909
Open AccessThe Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity
Background/Objectives: The association between past coronavirus disease-19 (COVID-19) infection and pulmonary thromboembolism (PTE) is a potential research topic. We aimed to research the prevalence of previous COVID-19 infection in patients with PTE and to determine whether there is a difference in embolism severity in these cases. Methods: Study design: Multicenter, observational, cross-sectional. Patients diagnosed with PTE between 11 March 2022 and 11 March 2023 were prospectively included in this study, excluding cases with PTE along with active COVID-19, patients under the age of 18, and pregnant patients. Group 1 consisted of PTE cases with previous COVID-19, and Group 2 consisted of PTE cases without previous COVID-19. Key variables are D-Dimer level, right ventricle/left ventricle (RV/LV) ratio, simplified pulmonary embolism severity score, and treatment type. Results: A total of 1185 patients (Group 1; n = 360, Group 2; n = 825) were included in this study. The proportion of patients with RV/LV ratio > 1 on computed tomography pulmonary angiography (CTPA) was significantly high in Group 2 compared to Group 1 (27.9% vs. 19.7%, p = 0.003). In multivariate logistic regression analysis, the absence of any identifiable risk factor for PTE was found to be a 0.46-fold protective factor in the presence of previous COVID-19 (OR: 0.456 95% CI: 0.274–0.760, Wald = 9.070, df = 1, p = 0.003) and an RV/LV ratio > 1 on CTPA was found to be a 0.60-fold protective factor (OR: 0.603, 95% CI: 0.365–0.998, Wald = 3.874, df = 1, p = 0.049). Conclusions: The prevalence of previous COVID-19 infection in PTE cases was 30.4%, and 26.3% of idiopathic cases had previous COVID-19 infection. Although the parameters related to embolism severity were higher in the non-COVID-19 group, multivariate analyses revealed a 2.2-fold increased risk for idiopathic PTE and a 1.7-fold increased risk for RV/LV ratio > 1 on CTPA in patients without COVID-19 compared to those with prior COVID-19.
- Open Access
- 7 November 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 698-705
Factors Affecting Treatment Compliance of Patients With COPD During the COVID-19 Pandemic
Objective: This study aimed to investigate the effects of difficulties experienced in the follow-up and treatment during the Coronavirus 2019 pandemic (COVID-19p), which included COVID-19 phobia and depression, on treatment compliance in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods: This study included 123 patients with COPD. The COVID-19 Phobia Scale (C19P-S), Beck Depression Inventory (BDI), and Medication Adherence Report Scale (MARS) were used to assess the patients. Results: The mean age of patients with COPD was 64.56 ± 9.31 years. It was determined that our patients did not maintain regular outpatient follow-up mostly because of the fear of COVID-19 transmission (78.8%). Overall, 24% of our patients showed treatment noncompliance. A statistically significant relationship was found between COPD stages B and D and treatment compliance (p=0.01). Patients with frequent emergency department admissions (p = 0.01) and those with high BDI (p = 0.01) and C19P-S (p = 0.02) scores during the pandemic were found to have reduced treatment compliance. Conclusion: Patients with COPD with COVID-19 phobia, and depression had reduced treatment compliance. İt is necessary to be aware of these conditions and to plan appropriate interventions.
- 7 November 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 698-705
Open AccessFactors Affecting Treatment Compliance of Patients With COPD During the COVID-19 Pandemic
Objective: This study aimed to investigate the effects of difficulties experienced in the follow-up and treatment during the Coronavirus 2019 pandemic (COVID-19p), which included COVID-19 phobia and depression, on treatment compliance in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods: This study included 123 patients with COPD. The COVID-19 Phobia Scale (C19P-S), Beck Depression Inventory (BDI), and Medication Adherence Report Scale (MARS) were used to assess the patients. Results: The mean age of patients with COPD was 64.56 ± 9.31 years. It was determined that our patients did not maintain regular outpatient follow-up mostly because of the fear of COVID-19 transmission (78.8%). Overall, 24% of our patients showed treatment noncompliance. A statistically significant relationship was found between COPD stages B and D and treatment compliance (p=0.01). Patients with frequent emergency department admissions (p = 0.01) and those with high BDI (p = 0.01) and C19P-S (p = 0.02) scores during the pandemic were found to have reduced treatment compliance. Conclusion: Patients with COPD with COVID-19 phobia, and depression had reduced treatment compliance. İt is necessary to be aware of these conditions and to plan appropriate interventions.
- Open Access
- 31 August 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (3) , 588-596
Predictors of Mortality in Pulmonary Embolism: A Real-Life Study
Objective: The primary aim of this study was to investigate the mortality and associated factors in patients with pulmonary embolism. Methods: A retrospective analysis was performed on adult patients with pulmonary embolism who applied to X University Hospital between January 1, 2017, and January 1, 2023. All-cause mortality and related factors in pulmonary embolism patients were determined. Results: This study included 152 patients with a median age of 59 years and 81 (53.3%) women. The all-cause mortality rate was 25.7%, and pulmonary embolism-related deaths were 1.3%. Age (p<0.001), chronic obstructive pulmonary disease (COPD) (p=0.013), heart failure (p=0.018), atrial fibrillation (p=0.015), massive pulmonary embolism (p=0.029), hemoglobin level (p<0.001) and NT-Pro BNP level (p<0.001) were significantly associated with increased all-cause mortality. In binary logistic regression analysis, for each unit of increasing pulmonary embolism severity index (PESI) score, mortality increased 2.2-fold (95% CI:1.03-5.09), massive PTE 1.6-fold (95% CI:0.14-17.86), anticoagulant duration (daily) 0.98-fold (95% CI:0.98-0.99) and Hb level (per unit Hb reduction) 0.67-fold (95% CI:0.45-1.02) mortality was increasing. There was no statistical difference between the number of hospitalization days for patients with low and high PESI and simplified PE severity index (sPESI) scores. Conclusions: All-cause mortality in patients with pulmonary embolism increased with age, cardiac diseases, and COPD comorbidities. The PESI and sPESI scores used in the acute phase of PTE were found to be highly reliable in predicting all-cause mortality in PE patients. The diagnosis of massive PE and elevated NT-proBNP levels, a marker of right ventricular dysfunction, were factors that increased mortality.
- 31 August 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (3) , 588-596
Open AccessPredictors of Mortality in Pulmonary Embolism: A Real-Life Study
Objective: The primary aim of this study was to investigate the mortality and associated factors in patients with pulmonary embolism. Methods: A retrospective analysis was performed on adult patients with pulmonary embolism who applied to X University Hospital between January 1, 2017, and January 1, 2023. All-cause mortality and related factors in pulmonary embolism patients were determined. Results: This study included 152 patients with a median age of 59 years and 81 (53.3%) women. The all-cause mortality rate was 25.7%, and pulmonary embolism-related deaths were 1.3%. Age (p<0.001), chronic obstructive pulmonary disease (COPD) (p=0.013), heart failure (p=0.018), atrial fibrillation (p=0.015), massive pulmonary embolism (p=0.029), hemoglobin level (p<0.001) and NT-Pro BNP level (p<0.001) were significantly associated with increased all-cause mortality. In binary logistic regression analysis, for each unit of increasing pulmonary embolism severity index (PESI) score, mortality increased 2.2-fold (95% CI:1.03-5.09), massive PTE 1.6-fold (95% CI:0.14-17.86), anticoagulant duration (daily) 0.98-fold (95% CI:0.98-0.99) and Hb level (per unit Hb reduction) 0.67-fold (95% CI:0.45-1.02) mortality was increasing. There was no statistical difference between the number of hospitalization days for patients with low and high PESI and simplified PE severity index (sPESI) scores. Conclusions: All-cause mortality in patients with pulmonary embolism increased with age, cardiac diseases, and COPD comorbidities. The PESI and sPESI scores used in the acute phase of PTE were found to be highly reliable in predicting all-cause mortality in PE patients. The diagnosis of massive PE and elevated NT-proBNP levels, a marker of right ventricular dysfunction, were factors that increased mortality.
- Open Access
- 1 July 2023
- Published by Medknow in Nigerian Journal of Clinical Practice
- Vol. 26 (7) , 928-933
Epidemiological Trends and Seasonal Dynamics of Tuberculosis in Southeastern Turkey
Background: Tuberculosis (TB) is an important public health issue. Determining TB trend and seasonal variability provides useful information for designing treatment strategies and control programs. Aim: The present study attempts to investigate the epidemiological trend and the seasonal variations. Materials and Methods: TB data containing 2450 cases were collected over a period of seven years in the province of Diyarbakir in southeast Turkey. Trend function and seasonal variability were investigated by statistical curve fitting, surface fitting, and autoregressive time series analysis. Results: The study revealed a gradually decreasing trend in the number of TB cases over a period of seven years. Total TB incidence had seasonal variations (P = 0.04); there was a greater number of TB cases between April and July, with a peak in June. There were significant monthly seasonal variations with June peaks among females (P < 0.001), in patients in the age groups of 0–15 (P < 0.001) and 36–45 years (P < 0.001), in new cases (P < 0.001) and in the patients with pulmonary TB (P = 0.01). The extra-pulmonary TB cases peak in May (P = 0.01). Pulmonary TB and TB patients in the 36–45 age group had summer peak, while the other groups peaked at spring. Conclusions: Spring and summer peaks detected in total TB cases and in many subgroups indicate that multicenter and comprehensive clinical studies are needed to explain these variations.
- 1 July 2023
- Published by Medknow in Nigerian Journal of Clinical Practice
- Vol. 26 (7) , 928-933
Open AccessEpidemiological Trends and Seasonal Dynamics of Tuberculosis in Southeastern Turkey
Background: Tuberculosis (TB) is an important public health issue. Determining TB trend and seasonal variability provides useful information for designing treatment strategies and control programs. Aim: The present study attempts to investigate the epidemiological trend and the seasonal variations. Materials and Methods: TB data containing 2450 cases were collected over a period of seven years in the province of Diyarbakir in southeast Turkey. Trend function and seasonal variability were investigated by statistical curve fitting, surface fitting, and autoregressive time series analysis. Results: The study revealed a gradually decreasing trend in the number of TB cases over a period of seven years. Total TB incidence had seasonal variations (P = 0.04); there was a greater number of TB cases between April and July, with a peak in June. There were significant monthly seasonal variations with June peaks among females (P < 0.001), in patients in the age groups of 0–15 (P < 0.001) and 36–45 years (P < 0.001), in new cases (P < 0.001) and in the patients with pulmonary TB (P = 0.01). The extra-pulmonary TB cases peak in May (P = 0.01). Pulmonary TB and TB patients in the 36–45 age group had summer peak, while the other groups peaked at spring. Conclusions: Spring and summer peaks detected in total TB cases and in many subgroups indicate that multicenter and comprehensive clinical studies are needed to explain these variations.
- Open Access
- 1 March 2023
- Published by Phoenix Medical Journal in Phoenix Medical Journal
- Vol. 5 (1) , 10-16
COVİD-19 Hastalarında Toraks BT Skoru: Nötrofil-Lenfosit Oranı, Monosit, Laktat Dehidrojenaz, Albümin ve Ferritin Arasındaki İlişki
Objective: Various Laboratory and vital parameters, including leukopenia, lymphopenia, neutrophil/lymphocyte ratio elevation, lactate dehydrogenase elevation, D-dimer and ferritin elevation, and low albumin can be used in the diagnosis and assessment of the severity of COVID-19 infection . Methods: The chest computed tomography (CT) scores, lymphopenia, neutrophil/lymphocyte ratio, neutrophil, lymphocyte, lactate dehydrogenase, albumin, C-reactive protein, white blood cells, platelets, basophil, eosinophil, monocytes, procalcitonin, D-dimer, ferritin, ages, genders, hospitalization units, oxygen-free fingertip saturations in room air, additional diseases and symptoms of 693 patients diagnosed with COVID-19 were recorded. The parameters of the patients were compared according to the severity of the chest CT score. Results: As a result of this study neutrophil/lymphocyte ratio was found to be significantly higher in the severe group when compared to the moderate group and the mild group. As chest CT score increased, lactate dehydrogenase level was higher at a statistically significant level in the severe group than in the mild group. Albumin levels were found to be lower in the severe group at a statistically significant level than in the mild group. Monocyte levels were found to be lower in the severe group at a statistically significant level when compared to the moderate and mild groups. Ferritin level was higher in the severe group at a statistically significant level when compared to the moderate and mild groups. When the practical effectiveness of using hematological and biochemical parameters to differentiate patients with severe CT scores from non-severe patients based on the chest CT score of the patients was examined by using the ROC Analysis, it was found that the neutrophil/lymphocyte ratio value had the strongest predictive ability (AUC, 0.787, SD=0.057, P
- 1 March 2023
- Published by Phoenix Medical Journal in Phoenix Medical Journal
- Vol. 5 (1) , 10-16
Open AccessCOVİD-19 Hastalarında Toraks BT Skoru: Nötrofil-Lenfosit Oranı, Monosit, Laktat Dehidrojenaz, Albümin ve Ferritin Arasındaki İlişki
Objective: Various Laboratory and vital parameters, including leukopenia, lymphopenia, neutrophil/lymphocyte ratio elevation, lactate dehydrogenase elevation, D-dimer and ferritin elevation, and low albumin can be used in the diagnosis and assessment of the severity of COVID-19 infection . Methods: The chest computed tomography (CT) scores, lymphopenia, neutrophil/lymphocyte ratio, neutrophil, lymphocyte, lactate dehydrogenase, albumin, C-reactive protein, white blood cells, platelets, basophil, eosinophil, monocytes, procalcitonin, D-dimer, ferritin, ages, genders, hospitalization units, oxygen-free fingertip saturations in room air, additional diseases and symptoms of 693 patients diagnosed with COVID-19 were recorded. The parameters of the patients were compared according to the severity of the chest CT score. Results: As a result of this study neutrophil/lymphocyte ratio was found to be significantly higher in the severe group when compared to the moderate group and the mild group. As chest CT score increased, lactate dehydrogenase level was higher at a statistically significant level in the severe group than in the mild group. Albumin levels were found to be lower in the severe group at a statistically significant level than in the mild group. Monocyte levels were found to be lower in the severe group at a statistically significant level when compared to the moderate and mild groups. Ferritin level was higher in the severe group at a statistically significant level when compared to the moderate and mild groups. When the practical effectiveness of using hematological and biochemical parameters to differentiate patients with severe CT scores from non-severe patients based on the chest CT score of the patients was examined by using the ROC Analysis, it was found that the neutrophil/lymphocyte ratio value had the strongest predictive ability (AUC, 0.787, SD=0.057, P
- 15 January 2023
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 29 (3) , 382-388
Prevalence of smoking among medical students and associated factors in Turkey
The goal of this study is to assess medical school students’ smoking rates, levels of addiction, factors influencing tobacco smoking, and attitudes toward tobacco information and bans.For this stud...
- 15 January 2023
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 29 (3) , 382-388
Prevalence of smoking among medical students and associated factors in Turkey
The goal of this study is to assess medical school students’ smoking rates, levels of addiction, factors influencing tobacco smoking, and attitudes toward tobacco information and bans.For this stud...
- Open Access
- 14 October 2022
- Published by Springer Nature in Research Square
Propolis protects the lungs from radiation-induced systemic oxidative damage
Background: Propolis is well known as an antioxidant natural product. This study aimed to detect the radioprotective effect of propolis against oxidative lung injury caused by cranial irradiation. Methods: Thirty-two rats were randomly divided into four equal groups. Group A, sham control group (n = 8); group B,propolis control group (n = 8);group C,irradiation alone group (n = 8);and group D,irradiation plus propolis group (n = 8). The latter two groups were exposed to a single dose (5 Gy) of cranial irradiation. The saline dosage was 1 mL/kg/day, and the propolis dosage was 80 mg/kg/day. The total oxidant status(TOS), total antioxidant status (TAS), oxidative stress index (OSI), arylesterase, lipid hydroperoxide (LOOH), ceruloplasmin, total thiol (SH), and paraoxonase (PON) levels of lung tissues were measured. Result: TOS, OSI, and lipid hydroperoxide levels were significantly higher in group C than in all other groups. TOS, OSI, and lipid hydroperoxide were significantly lower, and TAS and total thiol levels were higher in group D than in group C. Conclusion: The use of propolis has a significant protective effect against the adverse effects of oxidative stress-related lung injury caused by ionizing radiation.
- 14 October 2022
- Published by Springer Nature in Research Square
Open AccessPropolis protects the lungs from radiation-induced systemic oxidative damage
Background: Propolis is well known as an antioxidant natural product. This study aimed to detect the radioprotective effect of propolis against oxidative lung injury caused by cranial irradiation. Methods: Thirty-two rats were randomly divided into four equal groups. Group A, sham control group (n = 8); group B,propolis control group (n = 8);group C,irradiation alone group (n = 8);and group D,irradiation plus propolis group (n = 8). The latter two groups were exposed to a single dose (5 Gy) of cranial irradiation. The saline dosage was 1 mL/kg/day, and the propolis dosage was 80 mg/kg/day. The total oxidant status(TOS), total antioxidant status (TAS), oxidative stress index (OSI), arylesterase, lipid hydroperoxide (LOOH), ceruloplasmin, total thiol (SH), and paraoxonase (PON) levels of lung tissues were measured. Result: TOS, OSI, and lipid hydroperoxide levels were significantly higher in group C than in all other groups. TOS, OSI, and lipid hydroperoxide were significantly lower, and TAS and total thiol levels were higher in group D than in group C. Conclusion: The use of propolis has a significant protective effect against the adverse effects of oxidative stress-related lung injury caused by ionizing radiation.
- 16 December 2019
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 35 (4) , 233-240
Comparison of the Effects of Smoking and Smokeless Tobacco “Maras Powder” Use on Pulmonary Function, Electrocardiogram and Other Parameters
- 16 December 2019
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 35 (4) , 233-240
Comparison of the Effects of Smoking and Smokeless Tobacco “Maras Powder” Use on Pulmonary Function, Electrocardiogram and Other Parameters
- Open Access
- 1 August 2018
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 13, 2367-2374
Prospective cross-sectional multicenter study on domiciliary noninvasive ventilation in stable hypercapnic COPD patients
Background: Domiciliary noninvasive ventilation (NIV) use in stable hypercarbic COPD is becoming increasingly widespread. However, treatment compliance criteria and factors related to compliance remain to be defined. Methods: This research was designed as a prospective, cross-sectional, multicenter real-life study. Chronic hypercapnic COPD patients who were using domiciliary NIV for at least 1 year and being followed up in 19 centers across Turkey were included in the study. The patients who used NIV regularly, night or daytime and ≥5 hours/d, were classified as “high-compliance group,” and patients who used NIV irregularly and Results: Two hundred and sixty-six patients with a mean age of 64.5±10.3 years were enrolled, of whom 75.2% were males. They were using domiciliary NIV for 2.8±2 years. Spontaneous time mode (pppp=0.049) and obesity (p=0.01) were significantly more frequent in the high-compliance group. There were no difference between 2 groups regarding hospitalization, emergency department and intensive care unit admissions within the last year, as well as modified Medical Research Council dyspnea and COPD Assessment Test scores. With regard to NIV-related side effects, only conjunctivitis was observed more frequently in the high-compliance group (p=0.002). Conclusion: Determination of the patients who have better compliance to domiciliary NIV in COPD may increase the success and effectiveness of treatment. This highly comprehensive study on this topic possesses importance as it suggests that patient and ventilator characteristics may be related to treatment compliance.
- 1 August 2018
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 13, 2367-2374
Open AccessProspective cross-sectional multicenter study on domiciliary noninvasive ventilation in stable hypercapnic COPD patients
Background: Domiciliary noninvasive ventilation (NIV) use in stable hypercarbic COPD is becoming increasingly widespread. However, treatment compliance criteria and factors related to compliance remain to be defined. Methods: This research was designed as a prospective, cross-sectional, multicenter real-life study. Chronic hypercapnic COPD patients who were using domiciliary NIV for at least 1 year and being followed up in 19 centers across Turkey were included in the study. The patients who used NIV regularly, night or daytime and ≥5 hours/d, were classified as “high-compliance group,” and patients who used NIV irregularly and Results: Two hundred and sixty-six patients with a mean age of 64.5±10.3 years were enrolled, of whom 75.2% were males. They were using domiciliary NIV for 2.8±2 years. Spontaneous time mode (pppp=0.049) and obesity (p=0.01) were significantly more frequent in the high-compliance group. There were no difference between 2 groups regarding hospitalization, emergency department and intensive care unit admissions within the last year, as well as modified Medical Research Council dyspnea and COPD Assessment Test scores. With regard to NIV-related side effects, only conjunctivitis was observed more frequently in the high-compliance group (p=0.002). Conclusion: Determination of the patients who have better compliance to domiciliary NIV in COPD may increase the success and effectiveness of treatment. This highly comprehensive study on this topic possesses importance as it suggests that patient and ventilator characteristics may be related to treatment compliance.